Adimab
Lebanon, NH, United States adimab.com
From their website, Nov 2026
Work here? Claim this listing
About
Adimab develops and engineers therapeutic biologics, with a focus on antibodies, multispecifics, and TCR-based proteins. It works with biopharma partners on discovery, engineering, and platform transfer from its operations in Lebanon, New Hampshire, and Mountain View, California.
Services
Antibody discovery
Develops therapeutic IgG and HCAb leads using fully human synthetic and immune libraries and a yeast-based platform.
Antibody engineering
Optimizes antibodies for specificity, affinity, stability, and developability across formats.
Multispecific antibodies and T cell engagers
Designs and assembles bispecific and higher-order multispecific antibodies and T cell engagers.
Protein and TCR engineering
Engineers soluble TCRs and other non-antibody proteins for binding, stability, specificity, and expression.
Funded discovery programs
Runs discovery and optimization projects for therapeutic proteins with Adimab scientists and delivers characterized antibody panels.
Platform transfer
Transfers Adimab’s yeast-based discovery platform into partner laboratories with training and ongoing support.
Non-exclusive programs
Provides validated discovery and engineering modules that can be used with existing workflows.
Funded discovery
Discovers antibody leads on Adimab’s platform and transfers them to partners for further development.
- Turnaround
- Within four months
- What to send
- Antigen inputs, including soluble, membrane-associated, membrane-spanning proteins, peptides, and glycans
Capabilities
- Assays and studies
- Antibodies · Bispecifics · Flow cytometry · Peptides · In vivo · Rodent models · CHO · MACS · FACS · Redirected cytotoxicity assay · Cytokine assay · Binding kinetics
11 more
Purity analysis · Functional testing · Cross-reactivity assessment · pH dependence assessment · Polyspecificity assessment · Real-time screening · Directed evolution · Deep mutational scanning · Cell-based function assay · Kinetic analysis · Analytical testing - Scale and capacity
- 140+ biopharma partnerships · 675+ therapeutic programs initiated · 90+ clinical programs initiated · 6 commercial products · 85+ molecules advanced to clinic · More than 1,000 antibodies optimized · More than 200 internal programs · Over a thousand optimized antibodies · Dozens of receptors and peptide–HLA complexes
- Therapeutic areas
- Biopharma · Therapeutic biologics · All disease areas · Oncology
Instruments and platforms
- Flow cytometry
- MACS
- FACS
Modalities and species
- Modalities
- Antibody · Bispecific · Peptide · Cell therapy
- Species and models
- Yeast · Llama · CHO cells · HEK cells · Mice · Llamas
Industries served
- Biopharma
Company
- Type
- CRDMO
- Founded
- 2007
Locations
- Address
- 7 Lucent Drive Lebanon, NH 03766 USA
- Sites
- Lebanon, USA · Mountain View, USA
- Serves
- worldwide
Contacts
- Phone
- +1 603.643.7110
Similar labs
Work here? Claim this listing